Profile
Joseph P.
Cotropia is the founder of Bioclonetics Immunotherapeutics, Inc. He previously worked as the Director & Chief Medical Officer at Enzolytics, Inc. and as an Assistant Professor-Immunology at The University of Texas M.D.
Anderson Cancer Center.
He completed his undergraduate education at The University of Texas at Austin and The University of Texas Southwestern Medical Center.
Joseph Cotropia active positions
| Companies | Position | Start |
|---|---|---|
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops human neutralizing monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy | Founder | - |
Former positions of Joseph Cotropia
| Companies | Position | End |
|---|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Corporate Officer/Principal | - |
| ENZOLYTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Joseph Cotropia
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Consumer Services |
Enzolytics, Inc.
Enzolytics, Inc. BiotechnologyHealth Technology Develops and commercializes of drugs for infectious disease treatments | Health Technology |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops human neutralizing monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy | Health Technology |
- Stock Market
- Insiders
- Joseph Cotropia
















